Infectious diseases, such as tuberculosis and invasive mycoses, represent serious health problems. As a part of our long-term efforts to find new agents for the treatment of these diseases, a new series of pyrazine analogs of chalcones bearing an isopropyl group in position 5 of the pyrazine ring was prepared. The structures of the compounds were corroborated by IR and NMR spectroscopy and their purity confirmed by elemental analysis. The susceptibility of eight fungal strains to the studied compounds was tested. The results have been compared with the activity of some previously reported propyl derivatives. The only strain that was susceptible to the studied compounds was Trichophyton mentagrophytes. It was found that replacing a non-branched propyl with a branched isopropyl did not have a decisive and unequivocal influence on the in vitro antifungal activity against T. mentagrophytes. In vitro activity against Trichophyton mentagrophytes comparable with that of fluconazole was exhibited by nitro-substituted derivatives. Unfortunately, no compound exhibited efficacy comparable with that of terbinafine, which is the most widely used agent for treating mycoses
Results and Discussion

Chemistry
The studied compounds were prepared using the method described in our previous papers [32] [33] [34] . Pyrazine-2-carbonitrile (1) was submitted to Minisci radical alkylation [35] [36] [37] to yield 5-isopropylpyrazine-2-carbonitrile (2) . Although the Minisci reaction has been widely used in synthetic organic chemistry [38] it was first applied to homolytic alkylation of pyrazine-2-carbonitrile by our research group [39, 40] . 5-Isopropylpyrazine-2-carbonitrile (2) was then converted to 1-(5-isopropylpyrazin-2-yl)ethan-1-one (3) using a procedure described in our previous papers [39, 40] . Modified Claisen-Schmidt condensation of 3 with substituted benzaldehydes gave the pyrazine congeners of chalcones 4a-4j (Scheme 1). To separate the products from the reaction mixtures, column chromatography using a mixture of light petroleum-ethyl acetate was necessary (except for compound 4h). The yields of the products ranged between 18%-43% for most examples. However, isolation of compounds 4e, 4f and 4j was difficult. A mobile phase with a low content of ethyl acetate (90:10) was used, but the yields remained very low (<10%). A similar problem has previously been observed with (E)-1-(5-alkylpyrazin-2-yl)-3-(2-methoxyphenyl)prop-2-en-1-ones, (E)-1-(5-alkylpyrazin-2-yl)-3-(4-methoxyphenyl)prop-2-en-1-ones and (E)-1-(5-alkylpyrazin-2-yl)-3-(4-chlorophenyl)prop-2-en-1-ones where alkyl was propyl, butyl, isobutyl or tert-butyl [33, 41] . This may be due to the lower reactivity of methoxy-and chloro-substituted benzaldehydes in the Claisen-Schmidt reaction or the high lipophilicity (log P = 2.8 for 4e and 4f and 3.48 for 4j) of these compounds which complicates their chromatographic separation. Purity of the products was checked by elemental analysis. Their structures were confirmed by their IR and NMR spectra. The values of the spin interaction constant J (15-16 Hz) corresponds to an E-configuration on the double bond. Scheme 1. Synthesis of the compounds 4a-4j. Reagents and conditions: (a) isobutyric acid, AgNO3, (NH4)2S2O8, water, 80 °C; (b) CH3MgI, Et2O; (c) substituted benzaldehyde, pyridine, Et2NH.
Biological Evaluation
Antifungal Activity
Like the chalcone analogs previously prepared by us [32] [33] [34] , the (E)-1-(5-isopropylpyrazin-2-yl)-3-(substituted phenyl)-prop-2-en-1-ones reported here were tested as potential antimycotic and antituberculous drugs. In vitro susceptibility of eight fungal strains to the studied compounds was determined and results are summarized in Table 1 . MICs of previously reported propyl derivatives R = 2-OH (4a); 3-OH (4b); 4-OH (4c); 3-OCH3, 4-OH (4d); 2-OCH3 (4e); 4-OCH3 (4f); 2-NO2 (4g); 3-NO2 (4h); 4-NO2 (4i); 4-Cl (4j) 5a-5j are given for comparison. The compounds were inactive or only weekly active against most strains, hence some comparison is possible only for Trichophyton mentagrophytes. In five cases (4a and 5a, 4b and 5b, 4c and 5c, 4d and 5d, 4j and 5j) the propyl derivative exhibited better potency than the corresponding isopropyl congener, which is in agreement with trends indicated in the Introduction. However, in four cases (4e and 5e, 4f and 5f, 4g and 5g, 4i and 5i) an opposite trend was observed, and in case of 4h and 5h comparison is not possible due to the insolubility of compound 4h.
Moreover, the differences in the potencies of propyl and isopropyl derivatives are sometimes very subtle. Therefore, it can only be concluded that replacing a non-branched propyl with a branched isopropyl does not have a decisive and unequivocal influence on the in vitro antifungal activity against T. mentagrophytes. Potency of (E)-1-(5-isopropylpyrazin-2-yl)-3-(2-nitrophenyl)-prop-2-en-1-one (4g), and (E)-1-(5-isopropyl-pyrazin-2-yl)-3-(4-nitrophenyl)prop-2-en-1-one (4i) was comparable to that of fluconazole, which is sometimes used for the treatment of mycoses caused by Trichophyton spp. [42, 43] , but lower than that of voriconazole and terbinafine. Terbinafine is most widely used agent to treat mycoses caused by dermatophytes and other fungi [42, 44] . Voriconazole belongs to the highly effective systemic antifungal drugs with a favourable risk-benefit ratio, and with distinct in vitro activity against dermatophytes, yeasts and some molds [45] but clinically it is used to treat invasive aspergillosis [46, 47] . The good potency of the nitro-substituted derivatives 4g and 4i is in a good agreement with our previous results [34] , confirming the positive influence of a nitro group on the B-ring on the antifungal potency of chalcone-like derivatives. 5g ˃500 ˃500 ˃500 ˃500 ˃500 ˃500 ˃500 250 ˃500 ˃500 ˃500 ˃500 ˃500 ˃500 ˃500 250 
Antimycobacterial Activity
Selected compounds were submitted to evaluation of antimycobacterial activity in the Tuberculosis Antimicrobial Acquisition and Coordination Facility (TAACF) through a research and development contract with the U.S. National Institute of Allergy and Infectious Diseases. The results are shown in Table 2 . As expected according to our previous results [34] , the best inhibition was displayed by 2-nitro (4g) and 4-nitro (4i) derivatives, but they were less potent than the previously reported (E)-1-(5-tertbutylpyrazin-2-yl)-3-(4-nitrophenyl)prop-2-en-1-one (MIC90 = 0.78 μg/mL). This confirms that tert-butyl is the best substituent for antimycobacterial potency. A lower efficacy was observed with 2-hydroxy-(4a) and 4-hydroxy-(4c) substituted compounds, which is also in agreement with our previous results [32, 34] . For moving compounds into in vivo testing MIC ≤ 6.25 µg/mL and an selectivity index (the ratio of the measured CC50 in VERO cells to the MIC) SI ≥ 10 are required. Unfortunately, the selectivity indexes of the two promising compounds were too low.
Experimental Section
Chemistry
Materials and Methods
Pyrazine-2-carbonitrile (Sigma-Aldrich, Prague, Czech Republic) was used as a starting compound. 5-Isopropylpyrazine-2-carbonitrile and 1-(5-isopropylpyrazin-2-yl)ethan-1-one were prepared as described previously [40] . Commercially available substituted benzaldehydes (Sigma-Aldrich) were used as the starting materials. Silpearl (Kavalier, Votice, Czech Republic) was used for flash column chromatography. The purity of the products was checked by TLC on Silufol UV 254 plates (Kavalier). Mixtures of light petroleum and ethyl acetate were used for TLC. Analytical samples were dried over anhydrous phosphorus pentoxide under reduced pressure at room temperature. Melting points were determined on a Boëtius apparatus and are uncorrected. Elemental analyses were performed on an EA 1110 CHNS instrument (CE Instruments, Milano, Italy). Infrared spectra were recorded in KBr pellets on a Nicolet Impact 400 IR spectrophotometer (Thermo Scientific, Waltham, MA, USA). Characteristic wavenumbers are given in cm 1-(5-Isopropylpyrazin-2-yl)ethan-1-one (0.01 mol) and a substituted benzaldehyde (0.01 mol) were dissolved in pyridine (4.4 mL). Diethylamine (0.73 g, 0.01 mol) was added, and the reaction mixture was stirred at 80-120 °C for 2 h. After cooling, the mixture was poured into ice water (200 mL), acidified to pH 3 with a few drops of acetic acid, and then refrigerated for 24 h. The separation of crude products from water depended on their character. Solid product 4h was filtered off and crystallized from anhydrous ethanol. Oily mixtures were extracted with diethyl ether and subjected to flash chromatography on silica gel. Light petroleum-ethyl acetate 60:40 (v/v) was used as the eluent for compounds 4a-4d and 4g, 80:20 (v/v) ratio of the two solvents was used for 4i, and compounds 4e, 4f and 4j were separated using light petroleum-ethyl acetate 90:10 (v/v). The fractions containing the desired compounds were combined and crystallized from anhydrous ethanol. Using this procedure, the following compounds were obtained: 188.2, 166.2, 148.7, 145.8, 144.0, 141.8, 141.6, 136.6, 134.6, 130.0, 124.8, 123.1 
(E)-3-(2-Hydroxyphenyl)-1-(5-isopropylpyrazin-2-yl)prop-2-en-1-one (4a)
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(E)-3-(3-Hydroxyphenyl)-1-(5-isopropylpyrazin-2-yl)prop-2-en-1-one (4b
(E)-3-(4-Hydroxyphenyl)-1-(5-isopropylpyrazin-2-yl)prop-2-en-1-one (4c)
(E)-1-(5-Isopropylpyrazin-2-yl)-3-(2-methoxyphenyl)prop-2-en-1-one (4e)
(E)-1-(5-Isopropylpyrazin-2-yl)-3-(4-methoxyphenyl)prop-2-en-1-one (4f)
Biological Evaluation
Evaluation of in Vitro Antifungal Activity
The antifungal activity of all compounds was evaluated by the modified microdilution broth CSLI standards [50, 51] Fungal inocula were prepared by suspending yeasts, conidia, or sporangiospores in sterile 0.85% saline. The cell density was adjusted using a Bürker's chamber to yield a stock suspension of 1.0 ± 0.2 × 10 5 CFU/mL and 1.0 ± 0.2 × 10 6 CFU/mL for yeasts and molds, respectively. The final inoculum was made by 1:20 dilution of the stock suspension with the test medium.
The compounds were dissolved in DMSO, and the antifungal activity was determined in RPMI 1640 media (KlinLab, Prague, Czech Republic) buffered to pH 7.0 with 0.165 M 3-morpholinopropane-1-sulfonic acid (Sigma-Aldrich, St. Louis, MO, USA). Controls consisted of medium and DMSO alone. The final concentration of DMSO in the test medium did not exceed 1% (v/v) of the total solution. The concentrations of the studied substances ranged from 500 to 0.488 μmol/L. The minimum inhibitory concentration (MIC), was defined as 80% or greater (for yeasts and yeast-like organisms-IC80), resp. 50% or greater (for molds-IC50) reduction of growth in comparison with the control. The values of MICs were determined after 24 and 48 h of static incubation at 35 °C. In the case of T. mentagrophytes, the MICs were recorded after 72 and 120 h due to its slow growth rate. Fluconazole, voriconazole and terbinafine were used as reference antifungal drug.
Evaluation of in Vitro Antimycobacterial Activity
Primary screening of all compounds was conducted at 6.25 μg/mL against Mycobacterium tuberculosis H37Rv (ATCC 27294) in the BACTEC 12B medium using the Microplate Alamar Blue Assay (MABA). Compounds exhibiting fluorescence were tested in the BACTEC 460-radiometric system [52] . Compounds demonstrating at least 90% inhibition in the primary screen were re-tested at lower concentrations against M. tuberculosis H37Rv to determine the actual minimum inhibitory concentration (MIC) in the MABA. The MIC is defined as the lowest concentration effecting a reduction in fluorescence of 90% relative to controls.
The compounds that exhibited promising antimycobacterial activity were tested for cytotoxicity (CC50) in VERO cells at concentrations less than or equal to 10 times the MIC for M. tuberculosis H37Rv. After 72-h exposure, viability was assessed on the basis of cellular conversion of 1-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) into a formazan product using the Promega CellTiter 96 Non-radioactive Cell Proliferation Assay. The selectivity index was then calculated as the ratio of the measured CC50 in VERO cells to the MIC described above.
Conclusions
A series of (E)-1-(5-isopropylpyrazin-2-yl)-3-phenylprop-2-en-1-ones with various substituents on the phenyl ring (ring B) was prepared and tested for antifungal and antimycobacterial activity. Their in vitro antifungal potency was compared to previously reported propyl analogs. Only Trichophyton mentagrophytes was susceptible to the tested compounds, and it was found that replacing a non-branched propyl with a branched isopropyl has no decisive and unequivocal influence on the in vitro antifungal activity against T. mentagrophytes. Unfortunately, no compound exhibited efficacy comparable with that of terbinafine, which is most widely used agent for treating mycoses caused by dermatophytes. In both biological assays, the highest in vitro potency was displayed by nitro-substituted derivatives. This confirms our previous findings about the positive effect of electron-withdrawing groups on the B-ring of chalcones on their antimicrobial activity.
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